Skip to content
Menu

NervGen Pharma Corp. NGEN

Full chart Compare
Set alert

Price alert · NGEN

All alert types
1.88 USD +0.25 (+15.34%)

Regular-session close

1.86 -0.02 -1.07%

After hours · Nov 13, 7:43 PM ET

1.62 Day range 1.94
1.28 52-week range 6.30
YTD
-66.43%
1 year
-23.27%
Market cap
202.14M
EPS (ttm)
-0.57
YTD return
-66.43%
1-year return
-23.27%
Volume
1.99M
Avg volume
564.88K
Open
1.68
Previous close
1.63
Day's range
1.62 – 1.94
52-week range
1.28 – 6.30

5D +0.53 (+39.26%)

1.401.601.80MonTueWedThuFri1.88

Fundamental scorecard

5 of 25 checks passed on NGEN’s reported financials

Value: 0/5ValueGrowth: 0/5GrowthProfitability: 0/5ProfitabilityFinancial health: 5/5HealthDividend: n/aDividend

5of 25 checks passed

  • Value 0 of 5
  • Growth 0 of 5
  • Profitability 0 of 5
  • Financial health 5 of 5
  • Dividend No data

Statements to Jun 30, 2026.

Financials — quick view

All financials
NGEN Revenue — quarterly 0
2007-Q1 20072007-Q2 20072007-Q3 20072007-Q4 20072008-Q1 20082008-Q2 20082008-Q3 20082024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
NGEN Net income — quarterly 10.80M
2007-Q1 20072007-Q2 20072007-Q3 20072007-Q4 20072008-Q1 20082008-Q2 20082008-Q3 20082024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
NGEN EPS — quarterly 0.12
2007-Q1 20072007-Q2 20072007-Q3 20072007-Q4 20072008-Q1 20082008-Q2 20082008-Q3 20082024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

News

Your note

Sign in to keep a note on NGEN — it syncs with the Stock Master app.